Abstract:Background Systemic sclerosis (SSc) is a chronic inflammatory disease with complex pathogenesis. The role of regulatory T cells (Tregs) in the development of SSc has started being studied during the last decade with new aspects being disclosed continuously. Although there is a general agreement in the medical literature regarding the decreased functional capacity of circulating Tregs in SSc, the alteration of absolute number of Treg cells as well as orther CD4 +T lymphocyte subsets in SSc is still unclear. Objectives The aim of the present study was to explore the absolute number status of CD4 +T subsets in peripheral blood of patients with SSc using our modified flow cryometric method and investigate whether the imbalance of Th17 and Treg cells can be corrected by supplementing low dose interleukin −2 (IL-2). Methods The peripheral CD4 +T subsets from 54 patients with SSc and 30 healthy control subjects were analysed. The patients were divided into the untreated group (n=29) and treated group (n=25). The patients were also divided into group A (n=28) who only used low-dose glucocorticoids (GCS), and group B (n=26) who also used immunosuppressant cyclophosphamide (CYC), methotrexate (MTX), leflunomide (LEF) or mycophenolate mofetil (MMF). In addition, 21 patients from 54 patients, given a small dose of IL-2 (50WIU) treatment for a 5 day course, divided into pre-treatment group and post-treatment group. Directly using the results from flow cytometry combined with internal standard beads, absolute number of peripheral CD4 +T subsets from the subjects in each group were calculated. Results Although there were some changes among CD4 +T cell subsets in peripheral blood from these SSc patients, the major alteration was the reductions of Treg cell absolute number. Compared with the normal controls, the number of CD4+CD25+FOXP3+Treg cells were significantly decreased in all patients (p=0.001), in untreated group (p=0.029), in treated group (p=0.029), in group A (p=0.006) and in group B (p=0.004). The ratio of Th17/Treg in total patients (p=0.008) and group B (p=0.001) were significantly higher than that in normal control group, and the group B was significantly higher than the group A (p=0.032). Moreover, the number of Th17 cells in group B was significantly higher than that in group A (p=0.023). After IL-2 treatment, the absolute number of CD4+CD25+FOXP3+Treg cells (p 0.05). Since Th17 cells increases significantly lower than Treg cells, so their ratio decreases significantly (p=0.001) to get re-balance. Conclusions The absolute number of peripheral CD4 +CD25+FOXP3+Treg cells decreased in untreated patients, indicating that this reduction arising from the disease itself. Our findings suggest that SSc progression is associated with the absolute decrease of peripheral Treg cells. Although there was no statistically significant different, absolute number of the Treg cells trended to decrease in patients treated with immunosuppressive agents. The use of IL-2 can effectively up-regulate Treg cells as well as increase Th17 to a certain extent, which restores the balance of Th17/Treg cells, but the long-term effect needs further investigation. Disclosure of Interest None declared

Chronodependent Effect of Interleukin-2 on Mouse Spleen Cells in the Model of Cyclophosphamide Immunosuppression

Comparison of Membrane-bound and Secreted TGFβ by IL-2 Activated Natural and Adaptive CD4+CD25+ Regulatory Cells from Healthy and Lupus-prone Mice

[Effect of FK506 and CSA on the Cell Survival of Engrafted HSC and the Level of IL-2 and IL-4 in Leukemia Mice].

IL-2 enhances effector function but suppresses follicular localization of CD8 T cells in chronic infection

THU0412 Absolute reduction of peripheral cd4 + regulatory t cell subset of patients with systemic sclerosis and its restoration by short-term and low dose il-2 treatment

Effects of Recombined Procine Lactoferrin-N on Immunological Function in Immunosuppressive Mice Induced by Cyclophosphamide

Effect of the Female Silkworm Moth Powder on Immuno Function in Mice

EFFECTS OF CRUDE POLYSACCHARIDES EXTRACT FROM MYTILUS EDULIS ON THE IMMUNE FACTORS IN IMMUNOSUPPRESSED MICE

Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared with Low-Dose Interleukin-2 in Systemic Lupus Erythematosus.

Low Dose Interleukin-2 Ameliorates Sjögren's Syndrome in a Murine Model

Low Dose Interleukin-2 Ameliorates Sjögren’s Syndrome in a Murine Model

Application of an intermediate concentration of cyclophosphamide does not specifically deplete regulatory T cells in a mouse experimental model

Interleukin-2 in vivo: production of and response to interleukin-2 in lymphoid organs undergoing a primary immune response to heterologous erythrocytes

Opposite Effects of High and Low Doses of Interleukin-2 on T Cell-Mediated Hepatitis in Mice (Interleukin-2 on Hepatitis).

Evaluation of natural killer cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate-dose pulsing

Effect of Orally Administered Bovine Colostrum on Cytokine Production in Vivo and in Vitro in Immunosuppressed Mice.

Immunomodulatory Effect of Tremella Polysaccharides against Cyclophosphamide-Induced Immunosuppression in Mice

Effect of Cordyceps militaris Polysaccharides on Immunity Function in Immunosuppressed Mice

Study of Synergistic Effects of Spirulina Platensis on Inducing IL-2

The effect of two glucan carboxymethyl derivatives with various substitution degrees on cyclophosphamide immunosuppression in mice

AB0052 Increased peripheral CD8+ T cell responses in sle by low-dose IL-2 treatment